Sorry, this entry is only available in Polish.
Powiązane
Legal Alert | The President of the OCCP announces greater supervision of the pharmaceutical industry
During a January meeting of the Parliamentary Committee on Economy and Development,[1] the President of the Office of Competition and…
07 Feb 2023
SK&S recommended in the Legal500 ranking – 2022
We are proud to announce that in this year’s edition of The Legal 500 we have been recommended in 13…
12 Apr 2022
New regulations regarding restrictions on the sale of energy drinks are now in force!
On January 1, 2024, an amendment to the Public Health Act entered into force, revolutionizing the energy drinks market in…
13 Feb 2024
SK&S’ transaction team has advised AniCura AB in the acquisition process of veterinary clinic “Gliwcka Przychodnia Weterynaryjna”
“SK&S’ transaction team has advised AniCura AB in the acquisition process of veterinary clinic “Gliwcka Przychodnia Weterynaryjna”. One of the…
05 Dec 2023
Legal Alert | New “Blue Guide” published!
At the end of June, the European Commission (EC) published an updated “Blue Guide”, which, first published in 2000, has…
27 Jul 2022
Issues regarding borderline products – medical devices & medicinal products
The introduction of Regulation (EU) 2017/745 on Medical Devices (“MDR”) gave rise to a number of questions regarding products which…
09 Aug 2022
Legal Alert | NSA judgment on sugar tax
“Sugars occurring naturally in beverages are not subject to the fee on foodstuffs and, as a result, their quantity (content)…
30 Jan 2023
ANTI-CRISIS SHIELD – regulatory changes
DISTRIBUTION Possible ’faster’ export/sale of products included on the list of products facing potential shortages in Poland. The Main Pharmaceutical Inspectorate (GIF) will be able…
02 Apr 2020
Legal Alert | Energy drinks for persons over the age of 18
In July last year, we reported that due to ongoing discussions, the possibility of limiting the sale of energy drinks…
18 Jul 2023
Legal Alert | Act of March 9, 2023 on clinical trials of medicinal products for human use
On March 21, 2023, the long-awaited act on clinical trials of medicinal products for human use was signed by the…
23 Mar 2023
SK&S advised AniCura AB in the acquisition process of veterinary clinic “Centrum Zdrowia Małych Zwierząt” in Poznań
SK&S’ transaction team has advised AniCura AB in the acquisition process of veterinary clinic “Centrum Zdrowia Małych Zwierząt” in Poznań,…
25 Apr 2024
SK&S advised Velocity Clinical Research on the acquisition of ClinMedica Research
SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of its first site…
09 Feb 2024
Legal Alert | Status of the CBD in 2024 – summary
The hemp market includes food products, cosmetic products, but also pharmaceutical raw materials or products for animals. What should an…
27 Feb 2024
Legal Alert | European Commission proposes more changes for medical devices
EU regulations on medical devices (MDR[1]) and in vitro diagnostic medical devices (IVDR[2]) have been applied for several years now…
29 Feb 2024
SK&S advised AniCura on partnership with veterinary clinic “Molicki”
We are pleased to inform that veterinary clinic “Molicki” located in Dąbrowa Górnicza has joined AniCura, a family of leading…
20 Mar 2023